Pharmacology
Latest News
FDA mandates five changes to iPLEDGE program for isotretinoin
The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
Original Research
Thiazide Diuretic Utilization Within the VA
A retrospective analysis of US Department of Veterans Affairs data examined whether thiazide diuretic prescribing patterns met 2017 American...
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
Latest News
New consensus guide on rare drug hypersensitivity reaction
To support clinicians in diagnosing and managing DRESS, a steering committee conducted a literature review to examine current research, identify...
News
FDA OKs new agent to block chemotherapy-induced neutropenia
Efbemalenograstim has been approved by the FDA to combat infections in adults being treated for nonmyeloid cancers.
News
Low-dose methotrexate carries higher risk for older patients with CKD
Adverse event data showed an increased risk of myelosuppression, sepsis, pneumotoxic effects, or hepatotoxic effects.
News
Long-term use of ADHD meds and CVD risk: New data
“Clinicians should be vigilant in monitoring signs and symptoms of cardiovascular diseases, particularly among those receiving higher doses.”
Latest News
At 52 weeks, complete hair regrowth rates still climbing on deuruxolitinib
Complete responses continued to increase in open-label extensions of phase 3 alopecia areata studies.
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Conference Coverage
Pharmacist-based strategy places more patients on statins
In two studies run in parallel fashion, testing different strategies, automatic referral to a pharmacist was superior to EHR alerts for increasing...